Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | SRPT | LKFT | ||
| Company | Abcellera Biologics Inc | Sarepta Therapeutics | Lakefront Biotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.67 | 17.42 | 28.25 | ||
| High | 6.24 | 17.99 | 28.69 | ||
| Low | 5.53 | 17.42 | 28.18 | ||
| Latest | 6.17 | 17.87 | 28.35 | ||
| Change | +0.44 | +0.57 | +0.03 | ||
| % Change | +7.68% | +3.29% | +0.11% | ||
| Volume | 9,333,300 | 3,654,600 | 117,800 | ||
| 20-Day Average Volume | 9,483,240 | 3,136,960 | 160,695 | ||
| Previous Close | 5.73 | 17.30 | 28.32 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.90 | 18.79 | 27.77 | ||
| 20-Day Raw Stochastic | 96.96% | 20.48% | 58.84% | ||
| 20-Day Relative Strength | 71.23 | 44.05 | 48.90 | ||
| Weighted Alpha | +161.32 | -27.23 | -7.68 | ||
| Today's Opinion | 72% Buy | 56% Sell | 88% Sell | ||
| Previous Opinion | 72% Buy | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 8% Sell | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.04% since 05/21/26 | +5.37% since 05/21/26 | +2.09% since 05/21/26 | ||
| Low | 5.04 on 05/22/26 | 16.42 on 05/26/26 | 27.24 on 05/26/26 | ||
| High | 6.24 on 05/29/26 | 17.99 on 05/29/26 | 28.69 on 05/29/26 | ||
| 1-Month | |||||
| %Chg | +61.52% since 04/29/26 | -13.55% since 04/29/26 | +1.76% since 04/29/26 | ||
| Low | 3.82 on 04/30/26 | 16.42 on 05/26/26 | 26.42 on 05/19/26 | ||
| High | 6.24 on 05/29/26 | 23.49 on 05/06/26 | 29.70 on 05/08/26 | ||
| 3-Month | |||||
| %Chg | +70.91% since 02/27/26 | +6.62% since 02/27/26 | -15.78% since 02/27/26 | ||
| Low | 3.22 on 04/07/26 | 15.52 on 03/06/26 | 26.42 on 05/19/26 | ||
| High | 6.24 on 05/29/26 | 23.85 on 03/25/26 | 34.42 on 03/05/26 | ||
| 6-Month | |||||
| %Chg | +65.42% since 11/28/25 | -16.26% since 11/28/25 | -9.48% since 11/28/25 | ||
| Low | 2.74 on 02/05/26 | 15.52 on 03/06/26 | 26.42 on 05/19/26 | ||
| High | 6.24 on 05/29/26 | 24.68 on 01/26/26 | 36.24 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,884,164 | 1,886,643 | 1,868,180 | ||
| Shares Outstanding, K | 305,375 | 105,576 | 65,897 | ||
| Annual Sales | 75,130,000 | 2,198,240,000 | 1,258,400,000 | ||
| Annual Net Income | -146,410,000 | -713,410,000 | 363,050,000 | ||
| Last Quarter Sales | 8,320,000 | 730,800,000 | 7,590,000 | ||
| Last Quarter Net Income | -43,170,000 | 330,960,000 | 16,960,000 | ||
| 60-Month Beta | 1.02 | 0.26 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.14 on 05/11/26 | 3.16 on 05/06/26 | 0.25 on 05/06/26 | ||
| Earnings Date | 08/06/26 | 08/05/26 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.03 | 0.00 | ||